New Weight-Loss shot brenipatide enters early human testing
NCT ID NCT07476118
First seen Mar 21, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study tests a new drug called brenipatide in 150 healthy adults with overweight or obesity. Participants receive injections under the skin to see how different doses affect body weight and safety. The study lasts about 42 weeks and aims to find out if the drug can help control weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit
RECRUITINGDallas, Texas, 75247, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit - Daytona Beach
RECRUITINGDaytona Beach, Florida, 32117-5116, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit Inc. - Madison
RECRUITINGMadison, Wisconsin, 53704, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.